Article History
Accepted: 10 November 2023
First Online: 2 January 2024
Competing interests
: S.J. has grants and consulting fees from Hansa Biopharma, CSL-Behring, Regeneron, Sana Biotechnology and Argenx. P.S.H. and M.C.H. declare no competing interests.